S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone
16 Nov 2022
The letter O is the focus of our Professors’ attention in this episode. They discuss the concept of ON/OFF, On Demand Therapies, and the importance of Opicapone....
Neurology
Movement Disorders
Latest Videos
Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics
02 Nov 2022
In this episode, Professor Werner Poewe and Bas Bloem discuss the letter G, with a particular focus on GBA and Genetics. Available now to stream on your favourite...
Levodopa Mythology – Dr Alberto Espay
24 Oct 2022
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
Reflections on Parkinson’s Disease Podcast – S2 EP3: ABC of PD – The Letter F: Fluctuations & Fatigue
17 Oct 2022
In Season 2, Episode 3, our Professors investigate the letter F, focusing on Fluctuations and Fatigue. Available now to stream on your favourite platform: Spotify Apple...
Prof. Angelo Antonini, MD, PhD – MDS Congress Madrid 2022
05 Oct 2022
We caught up with Prof. Angelo Antonini at the MDS Congress in Madrid to answer the following questions: 1. What is the need for treatment strategies that provide more...
Reflections on Parkinson’s Disease Podcast – S2 EP2: ABC of PD – The Letter E: Early Morning Off, Evidence, Exercise, Early PD
06 Sep 2022
In this latest episode of S2: ABC of Parkinson’s Disease, both Prof. look into the letter E where they discuss Early Morning Off, Evidence, Exercise, Early PD....
The role of on-demand medications in Parkinson’s Disease – Prof. Joaquim Ferreira, Prof. Angelo Antonini & Dr Susan Fox
15 Aug 2022
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
Reflections on Parkinson’s Disease Podcast – S2 EP1: ABC of PD – The Letter C: COMT Inhibitors, Continuous Dopaminergic Delivery
01 Aug 2022
In this new season, Prof. Poewe and Prof. Bloem will be discussing the ABC of Parkinson’s Disease – each episode will have a certain letter attributed to the many...
Charco Neurotech – CUE1: Prof. James Kilner
15 Jun 2022
In this exclusive interview, Charco Neurotech spoke to Professor James Kilner of the Human Motor Neuroscience department at Queen’s Square, University College of...
Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi
11 May 2022
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri
21 Mar 2022
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 1 CME credit...
An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi
18 Feb 2022
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke
14 Feb 2022
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 1 CME credit...
Oruen Testimonial by Dr. Monica Kurtis
11 Jan 2022
A testimonial on Oruen by Dr Monica Kurtis Director of the Movement Disorders Program, Neurology Department – Hospital Ruber Internacional, Madrid, Spain...
Reflections on Parkinson’s Disease Podcast – EP7: Apomorphine and non-motor symptoms
20 Dec 2021
In this episode of Reflections On Parkinson’s Disease, both professors dive into the history of Apomorphine, the role of the drug within each of their...
The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante
14 Dec 2021
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri
19 Nov 2021
Professor K Ray Chaudhuri MD, DSc, FRCP, FEAN, Professor of Movement Disorders and Neurology at King’s College Hospital, London, England. In this video, Prof....
Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis
26 Oct 2021
An exclusive 1:1 interview, featuring industry leading expert; Dr. Monica Kurtis, MD: Movement Disorders Program, Neurology Department – Hospital Ruber...
Reflections on Parkinson’s Disease Podcast – EP6: Talking PD – Issues in doctor-patient communication
20 Aug 2021
In episode 6, both Prof’s address the different experiences that they have encountered with their patients during their many years as PD specialists. They discuss ways...
Reflections on Parkinson’s Disease Podcast – EP5: The Hardships Of Being Off
15 Jul 2021
In this latest Episode of Reflections on Parkinson’s Disease, Prof’s Bloem and Poewe discuss what is meant by ‘on/off’ fluctuations and what it entails. They evaluate...
Reflections on Parkinson’s Disease Podcast – EP4: Response Fluctuations in Parkinson’s Disease and why they can be missed
11 Jun 2021
In the anticipation of Euro 2020, both Professor’s share their thoughts on who they will be supporting at this years tournament, before delving into the topic of...
Reflections on Parkinson’s Disease Podcast – EP3: Why PD patients start to fluctuate
22 May 2021
In Episode 3, Profs. Poewe and Bloem discuss why Parkinsons Disease patients develop fluctuations, how they can be treated & what mechanisms effect this. They also...
‘Wearing off’ to L-DOPA and its underlying mechanisms
05 May 2021
An exclusive 1:1 interview, featuring industry leading expert; Prof. Peter Jenner, Emeritus Professor of Pharmacology, King’s College London, UK This interview was...
Reflections on Parkinson’s Disease Podcast – EP2: Motor Fluctuations and the levodopa long-duration response
30 Apr 2021
In this episode, Bas and Werner delve into the term ‘motor fluctuations’ which is linked to the long-term experience patients have with Levodopa. They discuss a study...
Reflections on Parkinson’s Disease Podcast – EP1: Levodopa Facts and Myths
08 Apr 2021
In this episode both Professors dispel the myths and misconceptions of a drug that’s been used for over 50 years. They discuss the idea of a “honeymoon...
Multidisciplinary care in PD – Does it make a difference?
12 Feb 2021
An exclusive duo interview, featuring the following industry leading experts: Professor Werner Poewe, & Professor Bas Bloem. This duo interview was supported by an...
Parkinson’s Disease – Patient Roleplay
14 Jan 2021
An exclusive patient roleplay, featuring the following industry leading expert: Donald Grosset BSc Hons & Parkinson’s Disease patient, John Sterling. CME...
Tailoring Levodopa according to patient characteristics
02 Nov 2020
An exclusive duo interview, featuring the following industry leading experts: Professor Werner Poewe, & Professor Bas Bloem. This duo interview was supported by an...
Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
09 Oct 2020
An exclusive 3 part 1:1 interview, featuring industry leading expert; Professor Fabrizio Stocchi Part 1 A knowledge of the COMT mechanism of action in humans and the...
Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients
25 Sep 2020
Prof. Joaquim Ferreira Highlights of the BIAL sponsored symposium at the 2020 MDS congress
Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients
25 Sep 2020
Prof. Hubert Fernandez Highlights of the BIAL sponsored symposium at the 2020 MDS congress
Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile
25 Sep 2020
Prof. Cheryl Waters Highlights of the BIAL sponsored symposium at the 2020 MDS congress
Nonmotor Symptoms In Parkinson’s Disease Recognition & Management
09 Jun 2020
An exclusive one to one interview with Professor Per Odin, Head of Office, Neurology, Lund University, Sweden This interview was supported by an independent educational...
A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation
18 May 2020
An exclusive panel discussion, featuring the following industry leading experts: Werner Poewe, Per Odin & Angelo Antonini This roundtable discussion was supported...
The impact of COVID-19 for families with Parkinson’s Disease
13 May 2020
An exclusive one to one interview with Professor Bas Bloem, Parkinson Centre Nijmegan (ParC), Radboud University Medical Centre This interview was supported by an...
Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease
05 Mar 2020
An exclusive one to one interview with Professor Werner Poewe, MD, PhD, Innsbruck Medical University, Innsbruck, Austria This interview was supported by an independent...
Oruen Testimonial by Professor Werner Poewe
19 Feb 2020
A testimonial on Oruen by Professor Werner Poewe, a valued board member. Professor Werner Poewe Clinical Neurologist & Professor of Neurology Innsbruck Medical...
Early use of Levodopa vs Levodopa-sparing strategies
08 Nov 2019
An exclusive one to one interview with Professor Joaquim Ferreira, Associate Professor of Neurology and Clinical Pharmacology (FMUL), Lisbon, Portugal This interview...
Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation
07 Nov 2019
This roundtable discussion was supported by an independent educational grant by Bial HOW TO OBTAIN CME CREDITS Participants requesting CME credits are required to...
Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5
18 Oct 2019
The EPDA website Parkinson’s Life – the online lifestyle magazine offering a voice to the global Parkinson’s community – launched its first podcast in May 2019....
Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol
16 Oct 2019
This interview was supported by an independent educational grant by Bial HOW TO OBTAIN CME CREDITS Participants requesting CME credits are required to complete the...
Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019)
11 Oct 2019
Early vs Late Use Of Levodopa – Angelo Antonini
12 Sep 2019
This interview was supported by an independent educational grant by Bial HOW TO OBTAIN CME CREDITS Participants requesting CME credits are required to complete the...
People over the world talk about their Parkinson’s – Chapter 1
29 Apr 2019
EPDA #UniteForParkinsons
29 Apr 2019
Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?”
02 Aug 2018
Once you have viewed the content in the video, click here to download and review the accompanying slide deck.
Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante
09 Jul 2018
Chairman’s introduction Prof. Werner Poewe Innsbruck, Austria Current Treatment of Fluctuations Prof. Fabrizio Stocchi Rome, Italy Managing Motor Fluctuations:...
What Is My Pd Journey?
14 Feb 2017
My PD Journey from Oruen on Vimeo.
New Developments In Parkinson’s Disease Management: Interviews With The Experts
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
New Developments In Parkinson’s Disease Management: Interviews With The Experts
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Critical Case Considerations
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Am Impakt: Apomorphine For Morning Akinesia Trial – Results
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Delayed ON And Wearing OFF – Complications
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Introduction To The Symposium
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
“I am David”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
14 Jan 2014
Watch this authentic and inspirational video about a dystonia patient telling their own dystonia story and how they cope with the impact of the disease. Dystonia...
“I am Cheryl”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
14 Jan 2014
Watch this authentic and inspirational video about a dystonia patient telling their own dystonia story and how they cope with the impact of the disease. Dystonia...
Latest Posts
Effect of vibrotactile stimulation with cueing on falls in Parkinson’s disease: case study
30 Aug 2022
What to do when the honeymoon wears off
13 Jan 2022
We highlight key messages from Bial’s satellite symposium at the International Congress of Parkinson’s Disease and Movement...
Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition
12 Jan 2021
The Next Frontier for Parkinson’s disease and Movement Disorders: The Middle East, North Africa and South Asia (MENASA) region
09 Dec 2020
An exclusive panel discussion, featuring the following global leading experts: Jawad A. Bajwa, MD, Jose Obeso MD, PhD & Christopher G....
What’s New In Parkinson’s Rating Scales?
27 Jul 2017
Rating scales aid Parkinson’s evaluation and are an important assessment tool for healthcare professionals. However, existing scales have...
Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens?
12 Jan 2017
The causes of dystonia are not fully understood and although currently available treatments can provide effective symptomatic relief, they...
Neuromelanin MR Imaging In Parkinson’s Disease
01 Jul 2016
The development and application of neuromelanin sensitive MR imaging has allowed the detection of significant changes in the substantia...
The Clinical Validation Of Objective Measurement Of Movement In Parkinson’s Disease
30 Jun 2016
Introduction Home based objective measures of bradykinesia and dyskinesia will be important in managing Parkinsons Disease (PD). The Aim...
Plotting A Better Pathway For Parkinson’s Disease: The My PD Journey Project
30 Jun 2016
A clinical scale that takes a broader, deeper view of PD symptoms is the latest milestone in a collaborative effort to resolve multiple...
Parkinson’s Life – A new ‘Webzine’ For The International Parkinson’s Community Now Live!
28 Oct 2015
A new and innovative magazine-style website has been launched to inspire and inform the international Parkinson’s community. Parkinson’s...
Treatment Options For Atypical Parkin-Sonisms
13 May 2015
Success in treating patients with atypical parkinsonisms remains exceedingly low. This finding probably relates to the widespread...
The Role Of Apomorphine In The Effective Management Of Parkinson’S Disease – Highlights From Cony 2014
29 Aug 2014
The 8th World Congress on Controversies in Neurology (CONy) held in Berlin in May 2014 provided a forum for neurologists and other...
Coming Up Next: Managing Motor Complications In Parkinson’s Disease
11 Sep 2013
João Massano, MD Department of Neurology, Hospital Pedro Hispano/ULS Matosinhos, Portugal Department of Clinical Neurosciences and...
Natural Toxins: Their Roles In Developing PD
05 Dec 2012
Dr. Mohamed Salama Head of Experimental Neurology Unit MERC, Mansoura University, Egypt In rural living, individuals are exposed to...
Drug Dosage, Gender Affect Impulsivity Prognosis in Parkinson’s
07 Sep 2012
The development and resolution of impulse control disorders in patients with Parkinson’s disease appears to be largely reliant on gender,...
Nocturnal Sleep Boosts Working Memory Training in Parkinson’s
03 Sep 2012
Nocturnal sleep enhances working memory training in patients with Parkinson’s disease but not in those with Lewy body dementia, results...
Physiotherapy Found to Have Short-Term Benefit in Parkinson’s
29 Aug 2012
Existing data support the use of physiotherapy in the treatment of Parkinson’s disease in the short term, but larger, randomized...
Drug For Alzheimer’s, Parkinson’s And MS Shows Promise
21 Aug 2012
A “one-size-fits-all” new class of drugs that targets a particular type of brain inflammation is showing early promise for the...
Family History Tops Parkinson’s Disease Risk Factors
01 Aug 2012
A family member with Parkinson’s disease confers the strongest risk for developing the disease, according to findings from the largest and...
Voice Disturbance Analysis Detects Parkinson’s
29 Jul 2012
Evidence that voice disturbances might be an additional clue to making a diagnosis of Parkinson’s disease was recently supported by a...
MCI in Parkinson’s Linked to Frontostriatal Dysfunction
26 Jul 2012
Parkinson’s disease patients with mild cognitive impairment have dysfunctional circuitry in brain networks involving the right dorsal...
Risk Factors Identified for Impulse Control Disorders in Parkinson’s
07 Jun 2012
Dopamine agonist–induced impulse control disorders may be more likely in Parkinson’s disease patients who smoke, drink, or consume...
Rotigotine Patch Has Favorable Results in Parkinson’s, Restless Legs
25 May 2012
A reformulated version of the previously withdrawn Neupro rotigotine patch had favorable results in separate studies of patients with...
Ocular Tremor a Possible Biomarker for Early Parkinson’s Disease
10 Apr 2012
Ocular fixation instability, also known as ocular tremor, is a pervasive and highly specific feature among patients with Parkinson’s...
Study Hints at Statins’ Protective Effect Against Parkinson’s
13 Mar 2012
Regular users of statins had a “marginally significant” lower risk of developing Parkinson’s disease than did nonusers in a...
Weight Lifting Improves Physical Function in Parkinson’s
20 Feb 2012
A 2-year weight-lifting program improved physical symptoms of Parkinson’s disease – including tremor – and seemed to slow their...
Tai Chi Improved Postural Stability in Parkinson’s Disease
09 Feb 2012
Tai chi improved postural stability and other functional outcomes in patients with mild to moderate Parkinson’s disease to a significantly...
Disparities Seen in Care of Parkinson’s Patients : Better clinical care associated with neurologists was often unavailable to women or minorities.
03 Dec 2011
Major Finding: Women and blacks with Parkinson’s disease both had 23% lower odds of receiving care from a neurologist than did men...
Symptom Triad May Identify Parkinson’s Risk
20 Nov 2011
Major Finding: Significantly more individuals with hyposmia had DAT levels of 65% or lower, compared with normosmic individuals (11% vs....
Exercise Improved Some Cognitive Function in Parkinson’s
04 Nov 2011
Major Finding: Exercise and medication use significantly improved cognitive function in patients with Parkinson’s disease based on...